New York City recorded 359 confirmed overdose deaths in the second quarter of 2026, the lowest quarterly count since 2019, according to a provisional Health Department report released in November. The figure is below the 401 deaths recorded in the first quarter and far below the quarterly peak of 859 in the final three months of 2022.
The longer trend also moved downward. The city recorded 3,070 overdose deaths in 2022, 3,056 in 2023, 2,206 in 2024 and 1,873 in 2025. Counts for 2024 through 2026 remain provisional and can rise as medical examiners complete investigations, so the most recent comparisons should be treated as an improving signal rather than a final tally.
Fentanyl remained the substance most commonly involved in overdose deaths, and opioids were present in about 74 percent of second-quarter cases. The report notes that a New Yorker still dies from an overdose approximately every six hours. The decline therefore represents hundreds of avoided deaths compared with the peak, while the current level remains a major public-health emergency.
Quarterly counts can change for several reasons, including the drug supply, access to treatment, naloxone availability, harm-reduction services, emergency response and patterns of substance use. The data do not assign the decline to one program. A responsible evaluation should compare neighborhoods, substances, age groups and service use while accounting for the time needed to finalize cause-of-death records.
The city points to a $12 million investment announced in May to expand recovery services, including the certification and employment of peer specialists. The four-year initiative is expected to create 500 positions through community organizations. Peer workers can connect people with treatment and support through lived experience, but the effect of the new positions should be measured after hiring and placement are complete.
Public reporting should also track unequal risk. A citywide decline can conceal neighborhoods or groups where deaths remain high or fall more slowly. The Health Department's detailed surveillance can help agencies direct outreach, naloxone and treatment capacity. Changes in the presence of fentanyl or other substances should be published quickly because the risk profile of the illicit supply can shift faster than annual summaries.
People seeking immediate mental-health or substance-use support can call or text 988 for counseling and referrals. Naloxone remains an emergency response to a suspected opioid overdose; it is not a substitute for medical evaluation. Anyone who witnesses a possible overdose should call emergency services, administer naloxone if available and follow dispatcher instructions.
The second-quarter result is the strongest evidence yet that the city's overdose death toll is moving away from its 2022 high. The next reports will show whether that progress continues and whether final revisions materially change the recent counts. The goal is not merely a lower quarterly statistic but a sustained reduction across boroughs, with treatment and recovery options available before an emergency occurs.
Families and service providers should also remember that the report counts deaths, not every overdose or nonfatal emergency. A falling death count can coexist with a large number of people needing care. Nonfatal-overdose data, emergency responses and treatment entry can provide earlier warning than mortality records. Publishing those indicators together would make it easier to see whether the city is preventing emergencies, improving survival after they occur, or achieving both across every borough and neighborhood.
Primary sources: NYC Health provisional overdose report for second quarter 2026; NYC Mayor's Office announcement on overdose data. Reviewed November 15, 2026. Development: Second-quarter overdose report released November 2026.